Compare, Analyse STRIDES PHARMA SCIENCE with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES PHARMA SCIENCE vs ACTAVIS (US) - Comparison Results

STRIDES PHARMA SCIENCE     Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 STRIDES PHARMA SCIENCE   ACTAVIS
EQUITY SHARE DATA
    STRIDES PHARMA SCIENCE
Mar-18
ACTAVIS
Dec-18
STRIDES PHARMA SCIENCE/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs1,14713,729-   
Low Rs6429,209-   
Sales per share (Unadj.) Rs317.23,367.7-  
Earnings per share (Unadj.) Rs7.8-1,084.7-  
Cash flow per share (Unadj.) Rs25.1354.9-  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs274.313,890.1-  
Shares outstanding (eoy) m89.50332.60-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.83.4 82.8%   
Avg P/E ratio x114.0-10.6 -1,078.4%  
P/CF ratio (eoy) x35.732.3 110.5%  
Price / Book Value ratio x3.30.8 395.0%  
Dividend payout %25.50-   
Avg Mkt Cap Rs m80,0583,814,612 2.1%   
No. of employees `0002.516.9 14.8%   
Total wages/salary Rs m4,3410-   
Avg. sales/employee Rs Th11,325.866,277.4 17.1%   
Avg. wages/employee Rs Th1,731.40-   
Avg. net profit/employee Rs Th280.1-21,348.0 -1.3%   
INCOME DATA
Net Sales Rs m28,3941,120,088 2.5%  
Other income Rs m94121,420 4.4%   
Total revenues Rs m29,3341,141,507 2.6%   
Gross profit Rs m3,96529,352 13.5%  
Depreciation Rs m1,540478,813 0.3%   
Interest Rs m1,96264,635 3.0%   
Profit before tax Rs m1,403-492,677 -0.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m-1680-   
Extraordinary Inc (Exp) Rs m-436125,652 -0.3%   
Tax Rs m97-6,244 -1.6%   
Profit after tax Rs m702-360,781 -0.2%  
Gross profit margin %14.02.6 532.9%  
Effective tax rate %6.91.3 547.2%   
Net profit margin %2.5-32.2 -7.7%  
BALANCE SHEET DATA
Current assets Rs m24,836459,401 5.4%   
Current liabilities Rs m18,993406,402 4.7%   
Net working cap to sales %20.64.7 434.9%  
Current ratio x1.31.1 115.7%  
Inventory Days Days7120 362.4%  
Debtors Days Days11366 171.0%  
Net fixed assets Rs m34,289126,788 27.0%   
Share capital Rs m8950-   
"Free" reserves Rs m23,6510-   
Net worth Rs m24,5464,619,838 0.5%   
Long term debt Rs m15,5131,626,813 1.0%   
Total assets Rs m65,4377,221,859 0.9%  
Interest coverage x1.7-6.6 -25.9%   
Debt to equity ratio x0.60.4 179.5%  
Sales to assets ratio x0.40.2 279.8%   
Return on assets %4.1-4.1 -99.3%  
Return on equity %2.9-7.8 -36.6%  
Return on capital %6.9-4.8 -142.4%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m14,9620-   
CASH FLOW
From Operations Rs m1,871400,165 0.5%  
From Investments Rs m5,826219,839 2.7%  
From Financial Activity Rs m-10,157-686,803 1.5%  
Net Cashflow Rs m-2,615-66,466 3.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 70.95 Rs / USD

Compare STRIDES PHARMA SCIENCE With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare STRIDES PHARMA SCIENCE With: AUROBINDO PHARMA  VENUS REMEDIES  DR. REDDYS LAB  DR. DATSONS LABS  DISHMAN PHARMA  



Today's Market

Sensex Ends 95 Points Higher; Automobile and IT Stocks Witness Buying(Closing)

Indian share markets traded rangebound throughout the day and ended marginally higher. Sectoral indices ended on a mixed note with stocks in the automobile sector.

Related Views On News

STRIDES PHARMA SCIENCE Announces Quarterly Results (1QFY20); Net Profit Up 1048.1% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 432 m (up 1048.1% YoY). Sales on the other hand came in at Rs 7 bn (up 3.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (4QFY19); Net Profit Up 7919.8% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 650 m (up 7919.8% YoY). Sales on the other hand came in at Rs 8 bn (up 26.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

STRIDES PHARMA SCIENCE 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of STRIDES PHARMA SCIENCE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of STRIDES PHARMA SCIENCE. Also includes updates on the valuation of STRIDES PHARMA SCIENCE.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES PHARMA SCIENCE SHARE PRICE


Oct 23, 2019 (Close)

TRACK STRIDES PHARMA SCIENCE

  • Track your investment in STRIDES PHARMA SCIENCE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE - STERLING BIOTECH COMPARISON

COMPARE STRIDES PHARMA SCIENCE WITH

MARKET STATS